• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dexcom Inc (NQ: DXCM )

    73.03 -0.64 (-0.87%)
    Streaming Delayed Price Updated: 10:40 AM EDT, Aug 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 568,467
    Open 74.14
    Bid (Size) 73.00 (1)
    Ask (Size) 73.05 (3)
    Prev. Close 73.67
    Today's Range 72.85 - 74.31
    52wk Range 62.34 - 142.00
    Shares Outstanding 400,700,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
    DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?. 
    Via Chartmill
    DXCM Class Action Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the DexCom Inc. Class Action
    From Robbins LLP
    Via GlobeNewswire

    Performance

    YTD
    -40.67%
    -40.67%
    1 Month
    +8.22%
    +8.22%
    3 Month
    -42.67%
    -42.67%
    6 Month
    -37.14%
    -37.14%
    1 Year
    -26.45%
    -26.45%

    More News

    Read More
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Decoding 18 Analyst Evaluations For DexCom
    Via Benzinga
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. (DXCM) Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients
    Via Benzinga
    Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?
    Via Investor's Business Daily
    DXCM INVESTOR ALERT: DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Robbins Geller Rudman & Dowd LLP
    Via Business Wire
    Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
    From DexCom, Inc.
    Via Business Wire
    ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
    From The Rosen Law Firm PA
    Via GlobeNewswire
    DXCM Investor Alert: Robbins LLP Reminds DexCom Inc. Shareholders of the Securities Class Action Lawsuit
    From Robbins LLP
    Via Business Wire
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
    From Law Offices of Howard G. Smith
    Via Business Wire
    NASDAQ: DXCM: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against DexCom, Inc.
    From Kessler Topaz Meltzer & Check, LLP
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. (DXCM) Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. (DXCM) Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT: Investors With Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    DXCM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That DexCom, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Robbins Geller Rudman & Dowd LLP
    Via Business Wire
    DEXCOM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DexCom, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against DexCom Inc.
    From Robbins LLP
    Via GlobeNewswire
    DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Is It Time to Buy July's Worst-Performing S&P 500 Stocks?
    Via The Motley Fool
    Topics Stocks
    Exposures US Equities
    S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    S&P 500, Nasdaq Look To Snap Best Win Streaks Of 2024
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.